Home › Funds › Parkman Healthcare Partners LLC › UPB

Parkman Healthcare Partners LLC position in UPB

UPSTREAM BIO INC · Health Care

Parkman Healthcare Partners LLC reported holding 935,247 shares of UPB (UPSTREAM BIO INC) in its Q2 2026 13F filing — a position valued at US$6.5M, representing 0.66% of its reported portfolio and ranking #49 among its reported holdings. Parkman Healthcare Partners LLC has disclosed UPB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)935.25K sh
Reported value held$6.47M
Portfolio Weight0.66%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's UPB position evolved

Parkman Healthcare Partners LLC first disclosed a stake in UPB in Q1 2025 at 233,563 shares (US$1.4M). The position peaked in Q4 2025 at 834,559 shares, worth US$22.7M. Across 6 filings, Parkman Healthcare Partners LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 935,247 shares valued at US$6.5M — an increase of 148,464 shares quarter over quarter.. Notable position changes include a 206% increase in Q2 2025 (shares rose 71% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 233.56K $1.43M New
Q2 2025 715.50K $7.86M Add
Q3 2025 843.50K $15.87M Add
Q4 2025 834.56K $22.66M Reduce
Q1 2026 786.78K $7.08M Reduce
Q2 2026 935.25K $6.47M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UPB and 13F data

UPB (UPSTREAM BIO INC) is a Health Care company. 56 other funds we track also report a position in UPB — the largest reported positions include ORBIMED ADVISORS LLC (US$39.4M), Decheng Capital LLC (US$18.9M), Enavate Sciences GP, LLC (US$17.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UPB

All UPB fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held UPB?

Parkman Healthcare Partners LLC has disclosed UPB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Parkman Healthcare Partners LLC's current position in UPB?

As of Q2 2026, Parkman Healthcare Partners LLC holds 935.25K shares of UPB (UPSTREAM BIO INC), valued at $6.47M, representing 0.66% of its reported portfolio and ranking #49.

Has Parkman Healthcare Partners LLC been buying or selling UPB?

In the latest 13F filing (Q2 2026), Parkman Healthcare Partners LLC increased its position in UPB. The position peaked in Q4 2025 at 834.56K shares.

Which other funds hold UPB?

Other major institutional holders of UPB include ORBIMED ADVISORS LLC, Decheng Capital LLC, Enavate Sciences GP, LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.